The use of probucol for correction of hydrolipoperoxidation disturbances in COPD patients who stopped smoking

D. D. Rackita, V. G. Makarova, V. Y. Garmash, D. R. Rackita (Ryazan, Russia)

Source: Annual Congress 2004 - Biological correlates of COPD
Session: Biological correlates of COPD
Session type: Thematic Poster Session
Number: 494
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. D. Rackita, V. G. Makarova, V. Y. Garmash, D. R. Rackita (Ryazan, Russia). The use of probucol for correction of hydrolipoperoxidation disturbances in COPD patients who stopped smoking. Eur Respir J 2004; 24: Suppl. 48, 494

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018

Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011

Complete smoking cessation is beneficial in older and more advanced COPD patients
Source: Eur Respir J 2010; 36: 216-217
Year: 2010


The impact of smoking cessation on respiratory symptoms in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 391s
Year: 2005

Recommendations for smoking cessation treatment in respiratory patients
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007



The influence of smoking on hydrolipoperoxidation in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 306s
Year: 2003

COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005


The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients
Source: Annual Congress 2006 - COPD therapy
Year: 2006


The cost-effectiveness of antidepressants for smoking cessation in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006

Effects of smoking history on the benefits of pulmonary rehabilitation in patients with COPD
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

Smoking cessation and COPD
Source: Eur Respir Rev 2013; 22: 37-43
Year: 2013



Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012

The SMOKE study: 1 year evaluation of an intensive multi-component smoking cessation programme for COPD outpatients
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005


The smoking cessation efficacy of bupropion hydrochloride sustained release tablets (BUP SR) versus placebo (PBO) in smokers with chronic obstructive pulmonary disease (COPD) with respect to age, gender, pack-year history and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 192s
Year: 2001

Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 503s
Year: 2004

Effectiveness of smoking cessation in patients with psychiatric disease
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012


Smoking cessation and prevention
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242
Year: 2006

Smoking cessation strategies in patients with COPD
Source: Eur Respir J 2013; 41: 727-734
Year: 2013



Nicotine addiction and smoking history determine compliance in COPD patients enrolled in pulmonary rehabilitation program
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008